JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
- Home
- APIC25
Join us for an enlightening session addressing the critical importance of early and accurate identification of Candida auris (C. auris). This pathogen has emerged as a global health concern and poses a significant threat to vulnerable patients. Delayed detection can lead to dangerous outbreaks in healthcare settings.
When: Tuesday, June 17, 2025
Time: 12:45–1:15 p.m.
Location: Exhibitor Theater - Booth #1937
Speaker: Sarah Elliott, PhD, Principal Scientist, Scientific Affairs
Protecting Patients: Molecular Detection of Candida auris Colonization using the Simplexa® C. auris Direct assay
Dr. Elliott will discuss the novel Simplexa® C. auris Direct assay—the first FDA De Novo granted molecular diagnostic test designed for the rapid and reliable detection of C. auris in patients suspected of colonization. Discover how this test can support your infection control strategies, safeguard patient health, and help prevent potentially deadly outbreaks.
Don't miss this opportunity to learn how Simplexa® C. auris Direct can play a pivotal role in combating the spread of C. auris and protecting our communities.
To 18 June 2025